Novavax Inc (NVAX)
$94.36 1.94 (2.01%)
19:59 EDT NVAX Stock Quote Delayed 30 Minutes
Previous Close $3.14
Market Cap 36.01B
PE Ratio -154.69
Volume (Avg. Vol.) 3.07M
Day's Range 93.51 - 98.61
52-Week Range 3.54 - 111.77
Dividend & Yield N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
- From InvestorPlace
- From the Web
AbbVie, Livongo, Walmart and Novavax were our top stock trades for Wednesday. That said, let's look at the charts to see what's going on.
Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.
A race to develop a coronavirus vaccine is on, and these red-hot Covid-19 vaccine stocks are leading the way.
Uber, Novavax, DraftKings and Aurora Cannabis were our top stock trades for Wednesday. Let's have a look at what the charts say.
Novavax (NVAX) news for Tuesday concerning funding for a vaccine to stop the novel coronavirus has NVAX stock rocketing higher.
Novavax (NVAX) news for Wednesday concerning a trial for a vaccine to treat the coronavirus from China has NVAX stock flying high.
Investors began buying up NVAX shares in anticipation of the Phase 3 clinical trial announcement. We wound up with a 130% gain on the trade.
Unlike the broader market, these stocks to buy have managed to hold up strong amid the ongoing public health crisis.
Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.
Novavax (NVAX) earnings for the vaccine company's fiscal fourth quarter of 2019 have NVAX stock heading higher after-hours Wednesday.
Tesla made its one-millionth car, while Delta expects to save $2 billion in fuel costs. Here's the stock market today.
Boeing shares tanked on more negative reports, while Uber rallied on an asset sale. Here's what happened in the stock market today.
Novavax (NVAX) news for Tuesday concerning the spread of a virus in China has NVAX stock heading higher as more investors pick up the stock.
For investors seeking out the ultimate high-risk, high-reward stocks, look no further than the biotech industry.
Novavax news for Thursday concerning an accelerated approval pathway for one of the company's drugs has NVAX stock soaring higher.
With the major indices showing signs of hesitancy, now is an ideal time to consider lesser-known but viable cheap stocks.
Navellier RatingsPowered by Portfolio Grader